Beryl Drugs Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lakh)
Beryl Drugs Ltd · Financial Result · 14 Nov 2026, 9:38 pm
Beryl Drugs Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lakh) ■ Revenue: 693 (+35.4% YoY | -5.0% QoQ) ■ EBITDA: 23.9 (-65.6% YoY | -36.7% QoQ) ■ EBITDA Margin (%): 3.5 (-1013 bps YoY | -173 bps QoQ) ■ PAT: 5.7 (+537.1% YoY | -74.3% QoQ) ■ EPS (INR): 0.11 (+450.0% YoY | -75.0% QoQ)
Original exchange filing (PDF)
More announcements from Beryl Drugs Ltd
- OUTCOME OF BOARD MEETING · 14 Nov 2026
- Beryl Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2026 ,inter alia, to consider and approve to consider and approve unaudited .... · 14 Nov 2026
- NON- APPLICABILITY CERTIFICATE UNDER REGULATION 57(5) FOR THE QUARTER ENDED 30.09.2026 · 08 Oct 2026
- VOTING RESULTS OF 33RD ANNUAL GENERAL MEETING HELD ON 29TH SEPTEMBER, 2026 · 01 Oct 2026
- PROCEEDINGS OF 33RD ANNUAL GENERAL MEETING · 29 Sept 2026
- considered and approved the increase in limit of material related party transactions with M/S. AMINOVA INFUSIONS PVT. LTD. · 29 Sept 2026
- OUTCOME OF 33RD ANNUAL GENERAL MEETING · 29 Sept 2026
- ANNUAL REPORT 2025-2026 · 04 Sept 2026
